Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2)-Reference-Cited by-同舟云学术

Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2)

Published:2023-10 Issue:10 Volume:176 Page:1396-1404
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Qaseem Amir¹^ORCID,Yost Jennifer²^ORCID,Abraham George M.³^ORCID,Andrews Rebecca⁴^ORCID,Jokela Janet A.⁵^ORCID,Miller Matthew C.⁶^ORCID,Humphrey Linda L.⁷,Humphrey Linda L.,Obley Adam J.,Akl Elie A.,Andrews Rebecca^ORCID,Dunn Andrew,Forciea Mary Ann,Haeme Ray,Jokela Janet A.,Kansagara Devan L.,Lee Rachael^ORCID,Mackey Katherine,Marcucci Maura,Miller Matthew C.,Saini Sameer D.,Tschanz CDR Mark P.,Wilt Timothy J.,Carroll Kate,Etxeandia-Ikobaltzeta Itziar^ORCID,Harrod Curtis^ORCID,Qaseem Amir,Shamliyan Tatyana^ORCID,Umana Karla,Yost Jennifer,

Affiliation:

1. American College of Physicians, Philadelphia, Pennsylvania (A.Q.)

2. American College of Physicians, Philadelphia, and Villanova University, Villanova, Pennsylvania (J.Y.)

3. University of Massachusetts Medical School and Saint Vincent Hospital, Worcester, Massachusetts (G.M.A.)

4. University of Connecticut, Mansfield, Connecticut (R.A.)

5. Carle Illinois College of Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois (J.A.J.)

6. Penn Medicine, Philadelphia, Pennsylvania (M.C.M.)

7. Portland Veterans Affairs Medical Center and Oregon Health & Science University, Portland, Oregon (L.L.H.).

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Reference18 articles.

1. Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 1)

2. Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase

3. Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study

4. Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

5. Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Evidence Review for the American College of Physicians (Version 2, Update Alert);Annals of Internal Medicine;2024-08

2. Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2, Update Alert);Annals of Internal Medicine;2024-08